[Form 4] Ellsworth Growth and Income Fund Ltd Insider Trading Activity

Rhea-AI Filing Summary

Agilysys, Inc. (AGYS) has filed a Form 144 indicating a forthcoming sale of 258 common shares, valued at approximately $29,253.59, through Fidelity Brokerage Services on 07 July 2025. The shares represent less than 0.001% of the 28,017,312 shares outstanding. The seller acquired the stock one day earlier (06 June 2025) via restricted-stock vesting as compensation. The same individual, identified as Chris Robertson, sold 500 shares for $55,632.75 on 12 June 2025. No additional financial metrics, earnings data, or strategic disclosures accompany the notice. The filing fulfils SEC Rule 144 requirements and signals a routine, small-scale insider liquidity event rather than a material corporate development.

Insights

Securities Analyst

TL;DR – Routine insider sale; immaterial to AGYS valuation.

The proposed sale equals roughly 0.0009% of shares outstanding and follows a recent 500-share sale by the same insider. Dollar value is negligible versus AGYS’s daily trading volume, implying no valuation impact. Such filings are common after restricted-stock vesting and do not, by themselves, imply negative sentiment. I view the disclosure as neutral for investors.

Corporate Governance Expert

TL;DR – Compliance with Rule 144; no governance red flags.

The insider affirms no undisclosed adverse information, and the sale is properly scheduled via a broker. Absence of a 10b5-1 plan date suggests discretionary timing, yet the minimal size and prompt disclosure mitigate governance concern. From a stewardship perspective, the event is non-impactful.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GABELLI MARIO J

(Last) (First) (Middle)

C/O GAMCO INVESTORS, INC.

ONE CORPORATE CENTER

(Street)

RYE NY 10580

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ELLSWORTH GROWTH & INCOME FUND LTD [ ECF.B ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			Control Person of Adviser

3. Date of Earliest Transaction (Month/Day/Year)
06/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Series B Cumulative Preferred Shares	06/26/2025		J(1)		320,000	D	$10	20,000	D
Series B Cumulative Preferred Shares								125,000	I	Associated Capital Group, Inc.(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares were surrendered in accordance with Right to Put to the Fund up to 100% of Outstanding Series B Cumulative Preferred Shares.

2. The shares reported reflect the total shares owned by Associated Capital Group, Inc. (ACG). Mario J. Gabelli is the Executive Chair and controlling shareholder of ACG. Mr. Gabelli has less than a 100% interest in ACG and disclaims beneficial ownership of the shares held by it which are in excess of his indirect pecuniary interest.

	Douglas R. Jamieson as Attorney-in-Fact for Mario J. Gabelli	07/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many AGYS shares are being sold under this Form 144?

The filing covers 258 common shares of Agilysys, Inc.

What is the estimated market value of the AGYS shares to be sold?

The aggregate market value is $29,253.59 based on the filing.

Who is the insider selling AGYS shares?

The seller is Chris Robertson, as noted in the past-transactions section.

When will the AGYS share sale occur?

The approximate sale date disclosed is 07/01/2025.

How significant is this sale relative to total AGYS shares outstanding?

The 258 shares represent less than 0.001% of the 28,017,312 shares outstanding.

Did the insider recently sell additional AGYS shares?

Yes. 500 shares were sold on 06/12/2025 for $55,632.75.